InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Billen Daniel. Officer active across 1 company, notably Aurinia Pharmaceuticals Inc.. Aggregated, 4 reports have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €76k. Activity tracked since 19 May 2023. The latest transaction was filed on 21 May 2024 (Cession). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Billen Daniel is a Director at Aurinia Pharmaceuticals Inc. (XNAS). He has 4 filings in total, and across the 4 sampled recent filings between 2023-05-23 and 2024-05-22, sales total 76388 EUR and the modal transaction nature is Cession.